IDEXX Laboratories, Inc. provided financial guidance for 2024. For the period, The company expects revenue of $3,930 million - $4,040 million. EPS $10.84 - $11.33.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
487.1 USD | +0.70% | +4.07% | -12.25% |
05-02 | BNP Paribas Adjusts Price Target on IDEXX Laboratories to $641 From $653 | MT |
05-02 | Goldman Sachs Adjusts Price Target on IDEXX Laboratories to $600 From $675 | MT |
EPS Revisions
- Stock Market
- Equities
- IDXX Stock
- News IDEXX Laboratories, Inc.
- IDEXX Laboratories, Inc. Provides Financial Guidance for 2024